- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the whole blood pharmacokinetics and comparative bioavailability (AUC0-∞, Cmax, Tmax and apparent t1/2) of 2 new granule formulations of ridaforolimus compared to the provisional market 10 mg ECT in healthy subjects.
Inclusion criteria
- Sarcoma